Blueberry Therapeutics Ltd.
Nano-powered drugs for infections and inflammation
Blueberry Therapeutics Ltd. plans to exploit nanopolymer drug delivery technologies to create safer and more effective therapeutics to treat inflammation and infection. It will start by targeting OTC indications using nanotechnology and off-patent drugs, as this will enable its candidates to move toward the market more quickly and generate revenue.